Katerina Sideri

Dr. Katerina Sideri

Assistant Professor, Department of Political Science and History/Centre of Political Research, Panteion University of Social and Political Science Athens Greece  

Email: katerina.sideri10@gmail.com

Tel: +30 28210 74058

Research Interests:

- IP law, policy and governance of artificial intelligence and biotechnology


Dr Sideri is assistant professor of political science at Panteion University in Athens, GreecePreviously she was a Marie Curie Individual Fellow based at the Bioethics Institute Gent, in Belgium, associate research fellow at the University of Oxford, Centre for SocioLegal Studies and lecturer in IP law at the University of Exeter. She has acted as an advisor for the Tech transfer office of the Agricultural University of Athens and the Tech transfer office of the University of Crete. Dr Sideri’s research interests include the link between innovation and democracy, technoscience studies, solidarity and vaccine hesitancy, Intellectual property law, governance and strategy, with a focus on algorithms, biotechnology and pharmaceuticals. She has published in journals such as Science and Public Policy. Journal of Law and the Biosciences Journal of Technology Transfer. European Law Journal. Her more recent monograph is Patents as Discourse on Life: Bioproperty, Biomedicine and Deliberative Governance.  (Routledge; 2014). She is now working on a new monograph with the title 'Innovation for Whose Good?'

Recent Books

Bioproperty, Biomedicine and Deliberative Governance - Patents as Discourse on Life

In this book, Katerina Sideri engages with a cluster of some of the most pressing social and ethical issues of our time concerning the appropriate role and limits of technological innovation. Sideri argues, that more attention needs to be paid to the potential role of institutions, such as patents, in reinforcing key ethical understandings about human behaviour, wellbeing, and the value of knowledge. This is a book that will be of great interest to anyone concerned with questions about the appropriate future role of biotechnology and of scientific innovation more broadly.’

Michael Parker, University of Oxford, UK